Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 2 Postoperative Complications 1 Neoplasms 1 Frailty 1 Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 28 Carboplatin 28 pembrolizumab 25 Bevacizumab 14 liposomal doxorubicin 12 Cisplatin 11 Gemcitabine 10 Radiotherapy 8 Drug Therapy 8 Cyclophosphamide 8 Blood Specimen Collection 8 Topotecan 7 Nivolumab 7 olaparib 6 Doxorubicin 6 niraparib 5 Therapeutics 5 Dexamethasone 5 pertuzumab 4 pazopanib 4 lenvatinib 4 fludarabine 4 cemiplimab 4 atezolizumab 4 Trastuzumab 4 Surveys and Questionnaires 4 Psychiatric Rehabilitation 4 Polymerase Chain Reaction 4 Fulvestrant 4 Docetaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Geriatric Assessment × Gynecologic × Clear all

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Hospices Civils de Lyon

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡